Hi Rigormortis,
My view is that Covid totally changed the pathway for IVX, mainly due to lockdowns.
The lockdowns meant that human trials could not begin so they focused on developing INV043.
This reset the whole process and now the pathway to trials has been set out as per Ann.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.43M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.5¢ | $4.65K | 34.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 119627 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 36828 | 3 |
View Market Depth
| Last trade - 10.07am 18/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |